Don’t Add Anakinra to Your COVID-19 Treatment Protocol

You’ll hear about anakinra (Kineret) to treat patients admitted with COVID-19...due to a new emergency use authorization.

This IL-1 inhibitor is now authorized for certain adults with SARS-CoV-2 at risk of progressing to severe respiratory failure.

These are patients on low- or high-flow supplemental oxygen...but NOT noninvasive or mechanical ventilation.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote